Quercetin and sulforaphane in combination suppress the progression of melanoma through the down‑regulation of matrix metalloproteinase-9

Pradhan,Saurabh  J.; Mishra,Rosalin; Sharma,Priyanka; Kundu,Gopal  C.

doi:10.3892/etm.2010.144

Quercetin and sulforaphane in combination suppress the progression of melanoma through the down‑regulation of matrix metalloproteinase-9

Authors:
- Saurabh J. Pradhan
- Rosalin Mishra
- Priyanka Sharma
- Gopal C. Kundu
View Affiliations

Affiliations: National Center for Cell Science, Pune 411 007, India
Published online on: August 26, 2010 https://doi.org/10.3892/etm.2010.144
Pages: 915-920

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Malignant melanoma is one of the most common types of cancer in the US and worldwide. The epidemiological data suggest that dietary modification may reduce the incidence of this disease. Quercetin (3,5,7,3',4'-tetrahydroxyflavone), a flavonoid isolated from onion, exhibits anti-oxidant, anti-inflammatory and anti-cancer effects. D,L-sulforaphane [1-isothiocyanato-4-(methylsulfinyl)-butane], a cruciferous vegetable-derived isomer isolated from broccoli, is highly effective in protection against cancer. Matrix metalloproteinases (MMPs), extracellular matrix degrading enzymes, are involved in embryogenesis, inflammation, angiogenesis and cancer. MMP-9 in particular plays a crucial role in the regulation of invasion, tumor growth and metastasis. Previous studies have reported that both quercetin and sulforaphane independently reduce tumor growth and metastasis in breast, prostate, lung and other types of cancers. However, the combined effects of quercetin and sulforaphane on the regulation of tumor growth and the mechanism(s) of actions underlying this process have not yet been investigated. In the present study, we report for the first time that quercetin and sulforaphane in combination inhibit the proliferation and migration of melanoma (B16F10) cells more effectively than either compound used alone. Moreover, these compounds in combination significantly suppressed melanoma growth as compared to their individual use in a mouse model. This combined effect was predominantly due to a decrease in MMP-9 expression in the mouse tumors. Taken together, our findings revealed that the administration of quercetin and sulforaphane in combination rather than alone may be a more effective approach for the treatment of malignant melanoma.

View Figures

View References

1.	Gray-Schopfer V, Wellbrock C and Marais R: Melanoma biology and new targeted therapy. Nature. 445:851–857. 2007. View Article : Google Scholar : PubMed/NCBI
2.	Verhoeven DT, Goldbohm RA, van Poppel G, Verhagen H and van den Brandt PA: Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev. 5:733–748. 1996.PubMed/NCBI
3.	Zhang SM, Hunter DJ, Rosner BA, Giovannucci EL, Colditz GA, Speizer FE and Willett WC: Intakes of fruits, vegetables, and related nutrients and the risk of non-Hodgkin's lymphoma among women. Cancer Epidemiol Biomarkers Prev. 9:477–485. 2000.
4.	Bedikian AY, Millward M, Pehamberger H, Conry R, Gore M, Trefzer U, Pavlick AC, DeConti R, Hersh EM, Hersey P, Kirkwood JM and Haluska FG: Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group. J Clin Oncol. 24:4738–4745. 2006. View Article : Google Scholar : PubMed/NCBI
5.	Musonda CA and Chipman JK: Quercetin inhibits hydrogen peroxide (H₂O₂)-induced NF-kappaB DNA binding activity and DNA damage in HepG2 cells. Carcinogenesis. 19:1583–1589. 1998.PubMed/NCBI
6.	Avila MA, Velasco JA, Cansado J and Notario V: Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res. 54:2424–2428. 1994.PubMed/NCBI
7.	Vijayababu MR, Arunkumar A, Kanagaraj P, Venkataraman P, Krishnamoorthy G and Arunakaran J: Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3). Mol Cell Biochem. 287:109–116. 2006. View Article : Google Scholar : PubMed/NCBI
8.	Choi S and Singh SV: Bax and Bak are required for apoptosis induction by sulforaphane, a cruciferous vegetable-derived cancer chemopreventive agent. Cancer Res. 65:2035–2043. 2005. View Article : Google Scholar : PubMed/NCBI
9.	Zhang Y, Tang L and Gonzalez V: Selected isothiocyanates rapidly induce growth inhibition of cancer cells. Mol Cancer Ther. 2:1045–1052. 2003.PubMed/NCBI
10.	Zhang W and Zhang F: Effects of quercetin on proliferation, apoptosis, adhesion and migration, and invasion of HeLa cells. Eur J Gynaecol Oncol. 30:60–64. 2009.PubMed/NCBI
11.	Braganhol E, Zamin LL, Canedo AD, Horn F, Tamajusuku AS, Wink MR, Salbego C and Battastini AM: Antiproliferative effect of quercetin in the human U138MG glioma cell line. Anticancer Drugs. 17:663–671. 2006. View Article : Google Scholar : PubMed/NCBI
12.	Dashwood RH and Ho E: Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol. 17:363–369. 2007. View Article : Google Scholar : PubMed/NCBI
13.	Juge N, Mithen RF and Traka M: Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci. 64:1105–1127. 2007. View Article : Google Scholar : PubMed/NCBI
14.	Singh AV, Xiao D, Lew KL, Dhir R and Singh SV: Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis. 25:83–90. 2004. View Article : Google Scholar : PubMed/NCBI
15.	Myzak MC, Tong P, Dashwood WM, Dashwood RH and Ho E: Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med. 232:227–234. 2007.PubMed/NCBI
16.	Thejass P and Kuttan G: Antimetastatic activity of sulforaphane. Life Sci. 78:3043–3050. 2006. View Article : Google Scholar : PubMed/NCBI
17.	Parks WC, Wilson CL and Lopez-Boado YS: Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol. 4:617–629. 2004. View Article : Google Scholar : PubMed/NCBI
18.	Shapiro SD: Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol. 10:602–608. 1998. View Article : Google Scholar : PubMed/NCBI
19.	Pyke C, Ralfkiaer E, Tryggvason K and Dano K: Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol. 142:359–365. 1993.PubMed/NCBI
20.	Zeng ZS and Guillem JG: Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells. Br J Cancer. 74:1161–1167. 1996. View Article : Google Scholar : PubMed/NCBI
21.	Houde M, de Bruyne G, Bracke M, Ingelman-Sundberg M, Skoglund G, Masure S, van Damme J and Opdenakker G: Differential regulation of gelatinase B and tissue-type plasminogen activator expression in human Bowes melanoma cells. Int J Cancer. 53:395–400. 1993. View Article : Google Scholar : PubMed/NCBI
22.	Rangaswami H, Bulbule A and Kundu GC: Nuclear factor inducing kinase plays crucial role in osteopontin induced MAPK/IKK dependent nuclear factor κB-mediated promatrix metalloproteinase-9 activation. J Biol Chem. 279:38921–38935. 2004.PubMed/NCBI
23.	Coussens LM, Tinkle CL, Hanahan D and Werb Z: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 103:481–490. 2000. View Article : Google Scholar : PubMed/NCBI
24.	Muroski ME, Roycik MD, Newcomer RG, van den Steen PE, Opdenakker G, Monroe HR, Sahab ZJ and Sang QX: Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis. Curr Pharm Biotechnol. 9:34–46. 2008. View Article : Google Scholar : PubMed/NCBI
25.	Ram M, Sherer Y and Shoenfeld Y: Matrix metalloproteinase-9 and autoimmune diseases. J Clin Immunol. 26:299–307. 2006. View Article : Google Scholar : PubMed/NCBI
26.	Xiao D, Choi S, Johnson DE, Vogel VG, Johnson CS, Trump DL, Lee YJ and Singh SV: Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene. 23:5594–5606. 2004. View Article : Google Scholar
27.	Behera R, Kumar V, Lohite K, Karnik S and Kundu GC: Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Carcinogenesis. 31:192–200. 2010. View Article : Google Scholar : PubMed/NCBI
28.	Philip S, Bulbule A and Kundu GC: Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J Biol Chem. 276:44926–44935. 2001. View Article : Google Scholar
29.	Chakraborty G, Jain S and Kundu GC: Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res. 68:152–161. 2008. View Article : Google Scholar
30.	Jain S, Chakraborty G and Kundu GC: The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C alpha/c-Src/IkappaB kinase alpha/beta-dependent prostate tumor progression and angiogenesis. Cancer Res. 66:6638–6648. 2006. View Article : Google Scholar : PubMed/NCBI
31.	Philip S and Kundu GC: Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J Biol Chem. 278:14487–14497. 2003. View Article : Google Scholar
32.	Jeong JH, An JY, Kwon YT, Rhee JG and Lee YJ: Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression. J Cell Biochem. 106:73–82. 2009. View Article : Google Scholar : PubMed/NCBI
33.	Aggarwal BB and Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 71:1397–1421. 2006. View Article : Google Scholar : PubMed/NCBI
34.	Lin CW, Hou WC, Shen SC, Juan SH, Ko CH, Wang LM and Chen YC: Quercetin inhibition of tumor invasion via suppressing PKCδ/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis. 29:1807–1815. 2008.PubMed/NCBI
35.	Zhang X-M, Huang S-P and Xu Q: Quercetin inhibits the invasion of murine melanoma B16BL6 cells by decreasing pro-MMP-9 via the PKC pathway. Cancer Chemother Pharmacol. 53:82–88. 2004. View Article : Google Scholar : PubMed/NCBI